Oguejiofor K, Hall J, Slater C, Betts G, Hall G, Slevin N, Dovedi S, Stern P L, West C M L
Translational Radiobiology Group, Institute of Cancer Sciences, Manchester Academic Health Science Centre, University of Manchester, Wilmslow Road, Manchester, UK.
The Christie NHS Foundation Trust, Manchester, Wilmslow Road, UK.
Br J Cancer. 2015 Sep 15;113(6):886-93. doi: 10.1038/bjc.2015.277. Epub 2015 Aug 27.
Patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC) have a better prognosis than those with HPV-negative tumours. There is interest in de-escalating their treatment but strategies are needed for risk stratification to identify subsets with a poor prognosis. This study investigated tumour-infiltrating lymphocytes (TILs) in relation to HPV tumour status and patient survival.
Biopsies from 218 patients diagnosed with OPSCC between 2002 and 2011, who underwent chemo/radiotherapy were analysed for HPV by PCR, in-situ hybridisation and p16 immunohistochemistry (IHC). One hundred and thirty-nine samples with concordant HPV detection were analysed for CD3, CD4, CD8 and FoxP3 expression in tumour and stromal regions using multiplexIHC and multispectral image analysis. Labelling of smooth muscle actin (SMA) identified activated stroma.
Human papillomavirus-positive compared with HPV-negative OPSCC had higher infiltration in both tumour and stromal areas of CD4 and CD8 T cells but not FoxP3 T regulatory cells. Only CD3+CD8+ stromal and not tumour area infiltration was associated with increased survival (P=0.02). There was significantly higher SMA expression in HPV-positive compared with -negative tumours, which did not correlate with survival.
Studies of TILs for risk stratification in OPSCC should assess stromal infiltration.
人乳头瘤病毒(HPV)阳性的口咽鳞状细胞癌(OPSCC)患者的预后比HPV阴性肿瘤患者更好。人们对降低其治疗强度很感兴趣,但需要风险分层策略来识别预后较差的亚组。本研究调查了与HPV肿瘤状态和患者生存相关的肿瘤浸润淋巴细胞(TILs)。
对2002年至2011年间诊断为OPSCC并接受化疗/放疗的218例患者的活检组织进行PCR、原位杂交和p16免疫组化(IHC)检测HPV。对139例HPV检测结果一致的样本,使用多重免疫组化和多光谱图像分析,分析肿瘤和基质区域中CD3、CD4、CD8和FoxP3的表达。平滑肌肌动蛋白(SMA)标记可识别活化的基质。
与HPV阴性的OPSCC相比,HPV阳性的OPSCC在肿瘤和基质区域中CD4和CD8 T细胞的浸润更高,但FoxP3调节性T细胞浸润并非如此。只有CD3 + CD8 +基质而非肿瘤区域的浸润与生存率增加相关(P = 0.02)。与HPV阴性肿瘤相比,HPV阳性肿瘤中SMA表达明显更高,且与生存率无关。
OPSCC中用于风险分层的TILs研究应评估基质浸润情况。